Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Not a member yet
3661 research outputs found
Sort by
Further delineation of Malan syndrome
Get PDFFil: Priolo, Manuela. Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli. Unità Operativa di Genetica Medica; Italia.Fil: Schanze, Denny. University Hospital Magdeburg. Institute of Human Genetics; Alemania.Fil: Tatton-Brown, Katrin. St. George's University Hospitals NHS Foundation Trust. London and South West Thames Regional Genetics Service. Institute of Cancer Research. Division of Genetics and Epidemiology; Reino Unido.Fil: Mulder, Paul A. Lentis Psychiatric Institute. Jonx Department of Youth Mental Health. Autism Team Northern-Netherlands; Países Bajos.Fil: Tenorio, Jair. Institute of Medical and Molecular Genetics; España.Fil: Kooblall, Kreepa. University of Oxford. Radcliffe Department of Medicine. Academic Endocrine Unit; Reino Unido.Fil: Hernández Acero, Inés. Hospital Universitario Central de Asturias. Genetics Unit; España.Fil: Alkuraya, Fowzan S. King Faisal Specialist Hospital and Research Center. King Abdulaziz City for Science and Technology. Saudi Human Genome Project. Department of Genetics; Arabia Saudita.Fil: Arias, Pedro. Institute of Medical and Molecular Genetics; España.Fil: Bernardini, Laura. Casa Sollievo della Sofferenza Foundation. Cytogenetics Unit; Italia.Fil: Bijlsma, Emilia K. Leiden University Medical Centre. Department of Clinical Genetics; Países Bajos.Fil: Cole, Trevor. Birmingham Women's and Children's NHS Foundation Trust. Department of Clinical Genetics; Reino Unido.Fil: Coubes, Christine. Hôpital Arnaud de Villeneuve. Hospital Center University De Montpellier. Département de Génétique Médicale; Francia.Fil: Dapia, Irene. Institute of Medical and Molecular Genetics; España.Fil: Davies, Sally. University Hospital of Wales. Institute of Medical Genetics; Reino Unido.Fil: Di Donato, Nataliya. Technical University Dresden. Institute for Clinical Genetics; Alemania.Fil: Elcioglu, Nursel H. Marmara University Medical School. Department of Pediatric Genetics; Turquía.Fil: Fahrner, Jill A. Johns Hopkins University School of Medicine. McKusick-Nathans Institute of Genetic Medicine. Department of Pediatrics; Estados Unidos.Fil: Foster, Alison. University of Birmingham. College of Medical and Dental Sciences. Institute of Cancer and Genomic Sciences; Reino Unido.Fil: García González, Noelia. Unit Hospital Universitario Central de Asturias; España.Fil: Huber, Ilka. Sørland Hospital; Noruega.Fil: Iascone, Maria. Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII. Laboratorio di Genetica Medica; Italia.Fil: Kaiser, Ann-Sophie. Heidelberg University. Institute of Human Genetics; Alemania.Fil: Kamath, Arveen. University Hospital of Wales. Institute of Medical Genetics; Reino Unido.Fil: Liebelt, Jan. SA Pathology. South Australian Clinical Genetics Services; Australia.Fil: Lynch, Sally Ann. University College Dublin. School of Medicine and Medical Sciences. Academic Centre on Rare Diseases; Irlanda.Fil: Maas, Saskia M. Academic Medical Center. Department of Clinical Genetics; Países Bajos.Fil: Mammì, Corrado. Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli. Unità Operativa di Genetica Medica; Italia.Fil: Mathijssen, Inge B. Academic Medical Center. Department of Clinical Genetics; Países Bajos.Fil: McKee, Shane. Belfast Health and Social Care Trust. Northern Ireland Regional Genetics Service; Irlanda del Norte.Fil: Menke, Leonie A. University of Amsterdam. Academic Medical Center. Department of Pediatrics; Países Bajos.Fil: Mirzaa, Ghayda M. Seattle Children's Research Institute. Center for Integrative Brain Research; Estados Unidos.Fil: Montgomery, Tara. Newcastle upon Tyne National Health Service Foundation Trust; Reino Unido.Fil: Neubauer, Dorothee. University Hospital Magdeburg. Institute of Human Genetics; Alemania.Fil: Neumann, Thomas E. Mitteldeutscher Praxisverbund Humangenetik; Alemania.Fil: Pintomalli, Letizia. Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli. Unità Operativa di Genetica Medica; Italia.Fil: Pisanti, Maria Antonietta. Antonio Cardarelli Hospital. Medical Genetic and Laboratory Unit; Italia.Fil: Plomp, Astrid S. Academic Medical Center. Department of Clinical Genetics; Países Bajos.Fil: Price, Sue. Northampton General Hospital National Health Service Trust. Department of Clinical Genetics; Reino Unido.Fil: Salter, Claire. Princess Ann Hospital. Wessex Clinical Genetics Service; Reino Unido.Fil: Santos-Simarro, Fernando. Institute of Medical and Molecular Genetics; España.Fil: Sarda, Pierre. Hôpital Arnaud de Villeneuve. Hospital Center University De Montpellier. Département de Génétique Médicale; Francia.Fil: Segovia, Mabel. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica; Argentina.Fil: Shaw-Smith, Charles. Royal Devon and Exeter National Health Service Foundation Trust; Reino Unido.Fil: Smithson, Sarah. University Hospitals Bristol National Health Service Trust; Reino Unido.Fil: Suri, Mohnish. Nottingham University Hospitals National Health Service Trust. Nottingham Clinical Genetics Service; Reino Unido.Fil: Valdez, Rita Maria. Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich. Genetics Unit; Argentina.Fil: Van Haeringen, Arie. Leiden University Medical Centre. Department of Clinical Genetics; Países Bajos.Fil: Van Hagen, Johanna M. Vrije Universiteit Medical Centre. Department of Clinical Genetics; Países Bajos.Fil: Zollino, Marcela. Catholic University. Institute of Medical Genetics. Department of Laboratory Medicine; Italia.Fil: Lapunzina, Pablo. Institute of Medical and Molecular Genetics; España.Fil: Thakker, Rajesh V. University of Oxford. Radcliffe Department of Medicine. Academic Endocrine Unit; Reino Unido.Fil: Zenker, Martin. University Hospital Magdeburg. Institute of Human Genetics; Alemania.Fil: Hennekam, Raoul C. University of Amsterdam. Academic Medical Center. Department of Pediatrics; Países Bajos.Malan syndrome is an overgrowth disorder described in a limited number of individuals. We aim to delineate the entity by studying a large group of affected individuals. We gathered data on 45 affected individuals with a molecularly confirmed diagnosis through an international collaboration and compared data to the 35 previously reported individuals. Results indicate that height is > 2 SDS in infancy and childhood but in only half of affected adults. Cardinal facial characteristics include long, triangular face, macrocephaly, prominent forehead, everted lower lip, and prominent chin. Intellectual disability is universally present, behaviorally anxiety is characteristic. Malan syndrome is caused by deletions or point mutations of NFIX clustered mostly in exon 2. There is no genotype-phenotype correlation except for an increased risk for epilepsy with 19p13.2 microdeletions. Variants arose de novo, except in one family in which mother was mosaic. Variants causing Malan and Marshall-Smith syndrome can be discerned by differences in the site of stop codon formation. We conclude that Malan syndrome has a well recognizable phenotype that usually can be discerned easily from Marshall-Smith syndrome but rarely there is some overlap. Differentiation from Sotos and Weaver syndrome can be made by clinical evaluation only
Bactericidal and Cytotoxic Activities of Polyphenol Extracts from Solanum tuberosum spp. tuberosum and spp. andigena Cultivars on Escherichia coli and Human Neuroblastoma SH-SY5Y Cells In Vitro
No full textFil: Silveyra, María Ximena. Universidad Nacional de Mar del Plata. Instituto de Investigaciones Biológicas; Argentina.Fil: Lanteri, María Luciana. Universidad Nacional de Mar del Plata. Instituto de Investigaciones Biológicas; Argentina.Fil: Damiano, Rocío Belén. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Epidemiología; Argentina.Fil: Andreu, Adriana Balbina. Universidad Nacional de Mar del Plata. Instituto de Investigaciones Biológicas; Argentina.Potatoes (Solanum tuberosum L.) are a good source of dietary antioxidant polyphenols. This study investigated the potential antioxidant, bactericidal, and cytotoxic activities in vitro of the phenolic compounds present in tubers of one S. tuberosum spp. tuberosum (Summerside), and three S. tuberosum spp. andigena (landraces Moradita, Waicha, and Santa María) cultivars. Both the content of phenolic acids, chlorogenic acids (CGAs) being the most abundant, and the antioxidant activity were higher in extracts from skin than from flesh. Extracts from Moradita flesh and Summerside skin showed bactericidal activity against Escherichia coli ATCC 25922 but failed to inhibit pathogenic E. coli O157. Both extracts lack pigmentation but do contain 5-CGA, caffeic, and ferulic acids. Positive control with gentamicin and commercial 5-CGA resulted in a complete inhibition of bacterial growth. In addition, all potato extracts and commercial 5-CGA diminished dose-dependently human neuroblastoma SH-SY5Y cell viability. Skin extracts were more potent than flesh extracts. Among flesh extracts, Moradita was the most potent. Together, our results suggest that Moradita flesh could provide a desirable source of important health-promoting substances. Findings indicate that the biological activity of potato extracts is a combination of various bioactive compounds and contribute to the revalorization of potato as a functional food
The classical Bordetella species and MALDI-TOF technology: a brief experience
No full textFil: Zintgraff, Jonathan. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Irazu, Lucía. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Lara, Claudia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Rodriguez, Marcelo. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Santos, Mauricio. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.The aim of this work was to evaluate and optimize the identification of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica (usually known as the classical Bordetella species) using Bruker Biotyper matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI-TOF MS)
Spatial difference in the incidence of Argentine Hemorrhagic Fever and composition and abundance of rodents in the assemblage
No full textFil: Piacenza, María F. Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba; Argentina.Fil: Calderón, Gladys E. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Enría, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Provensal, María C. Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba; Argentina.Fil: Polop, Jaime J. Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba; Argentina.The Argentine Hemorrhagic Fever (AHF) is a zoonotic disease endemic in a wide area of the humid pampa of Argentina. The etiologic agent is the Junin virus that is maintained in the wild by the rodent Calomys musculinus and transmitted to humans, mainly, through aerosols generated from secretions and excretions
Outbreak of hantavirus pulmonary syndrome in Tucumán, Argentina
No full textFil: Calderón, Gladys E. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Brignone, Julia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Martin, María Laura. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Calleri, Fabián. SwissMedical Medicina Privada, San Miguel de Tucumán; Argentina.Fil: Sen, Carina. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Casas, Natalia. Programa Nacional de Control de Enfermedades Zoonóticas - Ministerio de Salud de la Nación; Argentina.Fil: Calli, Rogelio. Ministerio de Salud Pública de la Provincia de Tucumán. Dirección de Epidemiología; Argentina.Fil: Sinchi, Anabel. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Enria, Delia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Fil: Levis, Silvana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Virales Humanas; Argentina.Se describe un brote de síndrome pulmonar por hantavirus en el departamento de Burruyacú, provincia de Tucumán. La detección en 2016 de un caso de hantavirosis en una joven de 23 años –en ese momento considerado el primero ocurrido en dicha provincia– promovió un estudio epidemiológico exhaustivo, que permitió detectar retrospectivamente otro caso ocurrido en un niño de 5 años, un mes antes, en el mismo departamento. La infección fue confirmada por serología en ambos casos (caso 1 en muestras de 4 y 7 días de evolución, caso 2 en muestra a los 4 días). En ambos casos el genotipo viral fue caracterizado como HU39694 y los contactos fueron serológicamente negativos. En las áreas fueron identificados roedores pertenecientes a los géneros Akodon y Calomys y a la especie Mus musculus, pero no a Oligoryzomys, el reservorio habitual del genotipo HU39694. Tampoco se detectaron anticuerpos anti-hantavirus en suero de los roedores capturados. La ausencia de registro de viajes a área endémica de este genotipo y los hábitos recreacionales de los pacientes, sumados a los resultados serológicos negativos para hantavirus en los contactos, permiten inferir la posible exposición de los pacientes a fluidos de roedores infectados durante actividades recreativas o sociales al aire libre en sus respectivas áreas de residencia. En conclusión, se demuestra la circulación en Tucumán del genotipo viral HU39694, hasta ahora considerado restringido a la región pampeana central. Se extiende así a Tucumán el área endémica de hantavirosis, pero no se identificó el reservorio en el área.
(EN) We describe an outbreak of hantavirus pulmonary syndrome in the Burruyacú Department, Province of Tucumán. The detection in 2016 of a case of hantavirosis affecting a 23-year-old woman, considered at that time to be the first case occurred in that province, promoted a thorough epidemiological study. The investigation allowed the retrospective detection of another case occurred one month earlier in a 5-year-old child in the same Department. In both cases, the infection was confirmed by serology (case 1 at days 4 and 7 of disease onset, case 2 at day 4) and the viral genotype was characterized as HU39694. The contacts of both cases were serologically negative for hantavirus. The rodents captured in the area belonged to genus Akodon, genus Calomys and species Mus musculus. Oligoryzomys, the known reservoir for this viral genotype, was not found. Specific anti-hantavirus antibodies were not detected in the captured rodents. Given that the patients had not visited hantavirus endemic areas and their contacts were negative for hantavirus, we infer that the patients were locally exposed to fluids of infected rodents during their usual social or recreational outdoor activities. In conclusion, we demonstrate that hantavirus HU39694 -a genotype until now considered to be restricted to the Central Pampas of the country- is circulating in the North Western province of Tucumán. The endemic area of hantavirosis is thus expanded to this province but the viral reservoir in the area has not yet been identified
Bartonella henselae : evidencia serológica en pacientes pediátricos con sospecha clínica de enfermedad por arañazo de gato
No full textFil: Armitano, Rita. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Bacteriología Especial; Argentina.Fil: Lisa, Agustina. Instituto de Zoonosis "Luis Pasteur"; Argentina.Fil: Martínez, Claudia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Bacteriología Especial; Argentina.Fil: Cipolla, Lucia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Bacteriología Especial; Argentina.Fil: Iachini, Ricardo. Instituto de Zoonosis "Luis Pasteur"; Argentina.Fil: Prieto, Monica. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Servicio Bacteriología Especial; Argentina.La enfermedad por arañazo de gato (EAG) es producida por Bartonella henselae. Afecta principalmente a niños y el reservorio es el gato doméstico. El diagnóstico de laboratorio se basa en la detección de anticuerpos por inmunofluorescencia indirecta (IFI). El objetivo de este trabajo fue analizar la evidencia serológica de infección por B. henselae en pacientes pediátricos que reunían criterios clínicos/epidemiológicos para la sospecha de EAG. Se estudió a 92 pacientes; de acuerdo con los resultados serológicos, estos fueron categorizados en 4 grupos: 1) IgG (+)/IgM (+), 31,5% (n = 29); 2) IgG (---)/IgM (+), 10,9% (n = 10); 3) IgG (+)/IgM (---), 9,8% (n = 9), y 4) IgG (-- )/IgM (---), 47,8% (n = 44). La divulgación de estos resultados intenta promover futuros trabajos que investiguen la seroprevalencia de Bartonella spp. en Argentina. Esto permitirá conocer la importancia de esta zoonosis en nuestra población y evaluar nuevos puntos de corte para esta técnica serológica
Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adaptation
Get PDFFil: Brynildsrud, Ola B. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Pepperell, Caitlin S. University of Wisconsin-Madison. School of Medicine and Public Health. Department of Medicine. Division of Infectious Disease; Estados Unidos.Fil: Suffys, Philip. Oswaldo Cruz Institute. Laboratory of Molecular Biology Applied to Mycobacteria; Brasil.Fil: Grandjean, Louis. Imperial College London. Department of Paediatric Infectious Diseases; Reino Unido.Fil: Monteserin, Johana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Debech, Nadia. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Bohlin, Jon. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Alfsnes, Kristian. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Pettersson, John O-H. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Kirkeleite, Ingerid. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.Fil: Fandinho, Fatima. Centro de Referência Professor Hélio Fraga. Laboratorio de Bacteriologia da Tuberculose; Brasil.Fil: Silva, Marcia Aparecida da. Centro de Referência Professor Hélio Fraga. Laboratorio de Bacteriologia da Tuberculose; Brasil.Fil: Perdigao, Joao. Universidade de Lisboa. Instituto de Investigação do Medicamento. Faculdade de Farmácia; Portugal.Fil: Portugal, Isabel. Universidade de Lisboa. Instituto de Investigação do Medicamento. Faculdade de Farmácia; Portugal.Fil: Viveiros, Miguel. Universidade Nova de Lisboa. Instituto de Higiene e Medicina Tropical. Unidade de Microbiologia Medica; Portugal.Fil: Clark, Taane. London School of Hygiene and Tropical Medicine. Faculty of Infectious and Tropical Diseases; Reino Unido.Fil: Caws, Maxine. Liverpool School of Tropical Medicine. Department of Clinical Sciences; Reino Unido.Fil: Dunstan, Sarah. University of Melbourne. Peter Doherty Institute for Infection and Immunity; Australia.Fil: Thai, Phan Vuong Khac. Pham Ngoc Thach Hospital for TB and Lung Diseases; Vietnam.Fil: López, Beatriz. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Kitchen, Andrew. University of Iowa. Department of Anthropology; Estados Unidos.Fil: Brown, Tyler S. Massachusetts General Hospital. Division of Infectious Diseases; Estados Unidos.Fil: van Soolingen, Dick. National Institute for Public Health and the Environment. Center for Infectious Disease Research, Diagnostics and Perinatal Screening; Países Bajos.Fil: O'Neill, Mary B. University of Wisconsin-Madison. School of Medicine and Public Health. Department of Medical Microbiology and Immunology; Estados Unidos.Fil: Holt, Kathryn E. London School of Hygiene and Tropical Medicine. Faculty of Infectious and Tropical Diseases; Reino Unido.Fil: Feil, Edward J. University of Bath. Milner Centre for Evolution. Department of Biology and Biochemistry; Reino Unido.Fil: Mathema, Barun. Columbia University. Mailman School of Public Health; Estados Unidos.Fil: Balloux, Francois. University College London. University College London Genetics Institute; Reino Unido.Fil: Eldholm, Vegard. Norwegian Institute of Public Health. Division of Infectious Diseases and Environmental Health; Noruega.On the basis of population genomic and phylogeographic analyses of 1669 Mycobacterium tuberculosis lineage 4 (L4) genomes, we find that dispersal of L4 has been completely dominated by historical migrations out of Europe. We demonstrate an intimate temporal relationship between European colonial expansion into Africa and the Americas and the spread of L4 tuberculosis (TB). Markedly, in the age of antibiotics, mutations conferring antimicrobial resistance overwhelmingly emerged locally (at the level of nations), with minimal cross-border transmission of resistance. The latter finding was found to reflect the relatively recent emergence of these mutations, as a similar degree of local restriction was observed for susceptible variants emerging on comparable time scales. The restricted international transmission of drug-resistant TB suggests that containment efforts at the level of individual countries could be successful
Tetraglochin andina Ciald.: A medicinal plant from the Argentinean highlands with potential use in vaginal candidiasis
No full textFil: Moreno, María Alejandra. Laboratorio de Investigación de Productos Naturales (LIPRON), Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET), Facultad de Ciencias Naturales e IML, Universidad Nacional de Tucumán; Argentina.Fil: Córdoba, Susana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.Fil: Zampini, Iris Catiana. Laboratorio de Investigación de Productos Naturales (LIPRON), Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET), Facultad de Ciencias Naturales e IML, Universidad Nacional de Tucumán; Argentina.Fil: Mercado, María Inés. Instituto de Morfología Vegetal. Área Botánica. Fundación Miguel Lillo, San Miguel de Tucumán, Tucumán; Argentina.Fil: Ponessa, Graciela. Instituto de Morfología Vegetal. Área Botánica. Fundación Miguel Lillo, San Miguel de Tucumán, Tucumán; Argentina.Fil: Alberto, María Rosa. Laboratorio de Investigación de Productos Naturales (LIPRON), Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET), Facultad de Ciencias Naturales e IML, Universidad Nacional de Tucumán; Argentina.Fil: Nader-Macias, M E Fatima. Centro de Referencia de Lactobacillos (CERELA-CONICET), Chacabuco 145, San Miguel de Tucumán, Tucumán; Argentina.Fil: Sayago, Jorge. Laboratorio de Investigación de Productos Naturales (LIPRON), Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET), Facultad de Ciencias Naturales e IML, Universidad Nacional de Tucumán; Argentina.Fil: Burgos-Edwards, Alberto. Laboratorio de Química de Productos Naturales, Instituto de Química de Recursos Naturales, Universidad de Talca; Chile.Fil: Schmeda-Hirschmann, Guillermo. Laboratorio de Química de Productos Naturales, Instituto de Química de Recursos Naturales, Universidad de Talca; Chile.Fil: Isla, María Inés. Laboratorio de Investigación de Productos Naturales (LIPRON), Instituto de Bioprospección y Fisiología Vegetal (INBIOFIV-CONICET), Facultad de Ciencias Naturales e IML, Universidad Nacional de Tucumán, Tucumán; Argentina.The Argentinean medicinal plant Tetraglochin andina Ciald, formerly classified as T. cristatum (Britton) Rothm is used in traditional medicine by inhabitants from Argentinean northwestern highlands (Puna) to treat candidiasis and as anti-inflammatory
The classical Bordetella species and MALDI-TOF technology: a brief experience
No full textFil: Zintgraff, Jonathan. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Irazu, Lucía. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Lara, Claudia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Rodriguez, Marcelo. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.Fil: Santos, Mauricio. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas. Departamento de Bacteriología. Servicio de Bacteriología Clínica; Argentina.The aim of this work was to evaluate and optimize the identification of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica (usually known as the classical Bordetella species) using Bruker Biotyper matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI-TOF MS)
